Management Review is eine regelmäßige, systematische Bewertung des Qualitätsmanagementsystems durch die oberste Leitung, um dessen fortlaufende Eignung, Angemessenheit, Wirksamkeit und Ausrichtung auf die strategische Richtung der Organisation sicherzustellen.
Complete Guide to Management Review
Management Review is a formal, recurring process required by ISO 13485 and other quality standards where an organization's top management evaluates the performance and effectiveness of the Quality Management System (QMS). These structured meetings ensure that the QMS remains appropriate for the organization's needs, adequately addresses regulatory requirements, and effectively delivers safe, compliant medical devices.
Regulatory and standards requirements:
ISO 13485:2016 Clause 5.6 - Management Review:
ISO 13485 mandates that top management review the organization's QMS at planned intervals to ensure continuing suitability, adequacy, and effectiveness. The standard requires:
- Reviews conducted at defined intervals (at minimum annually, but often quarterly or semi-annually)
- Documented procedures for management review
- Review includes assessment of opportunities for improvement and need for changes to QMS
- Records maintained of management review meetings
FDA Quality System Regulation 21 CFR 820.20(b):
While not explicitly called "management review," FDA QSR requires management with executive responsibility to review the suitability and effectiveness of the quality system at defined intervals, ensuring it meets requirements and the organization's quality policy.
EU MDR Annex IX:
Notified Body audits verify that top management reviews the QMS to ensure continuing effectiveness and compliance with MDR requirements.
Purpose and objectives:
Management Review serves multiple critical functions:
- Verify QMS continues to meet ISO 13485, regulatory, and customer requirements
- Assess overall effectiveness in achieving quality objectives
- Identify opportunities for improvement and innovation
- Ensure adequate resources allocated to quality and regulatory compliance
- Review changing regulatory landscape and update strategies
- Demonstrate top management commitment to quality
- Align QMS performance with business strategy
- Address systemic issues identified through audits, complaints, or nonconformances
- Make strategic decisions about product portfolio, market expansion, or process changes
Required inputs to Management Review:
ISO 13485 specifies minimum inputs that must be considered:
1. Audit Results
- Internal audit findings and trends
- External audits (Notified Body, MDSAP, FDA inspections)
- Customer audits
- Status of audit corrective actions
2. Customer Feedback
- Customer satisfaction surveys and scores
- Complaint trends and analysis
- Product returns and field actions
- Customer communications and concerns
3. Process Performance and Product Conformity
- Key performance indicators (KPIs) and metrics
- Production yields and scrap rates
- Nonconformance rates and trends
- First-pass yield statistics
- Process capability indices
4. Status of Preventive and Corrective Actions
- CAPA effectiveness and closure rates
- Overdue CAPAs and aging analysis
- Recurring issues indicating ineffective CAPA
- Preventive action implementation
5. Follow-up Actions from Previous Management Reviews
- Status of action items from prior meetings
- Effectiveness of previously decided changes
- Completion of resource allocations
6. Changes Affecting QMS
- Regulatory changes impacting operations
- New product introductions
- Process changes or improvements
- Organizational changes
- Technology or equipment updates
- Changes in suppliers or outsourced processes
7. Recommendations for Improvement
- Process improvement initiatives
- Technology upgrades
- Training needs
- Resource requirements
- Efficiency enhancement opportunities
8. New or Revised Regulatory Requirements
- Updates to regulations (MDR, IVDR, FDA guidance)
- Changes to standards (ISO 13485 revisions)
- New regulatory submissions or registrations
- Inspection observations or trends
9. Post-Market Surveillance Data
- Adverse events and vigilance reports
- Field safety corrective actions
- Market surveillance findings
- Competitor recalls and safety issues
10. Risk Management Review
- Updates to product risk assessments
- New hazards identified post-market
- Risk-benefit evaluations
- Residual risk acceptability
Required outputs from Management Review:
Management review must produce documented decisions and actions including:
1. Improvement of QMS Effectiveness
- Changes to processes or procedures
- Updates to QMS documentation
- Resource reallocation for quality improvement
2. Improvement Related to Regulatory Requirements
- Gap analysis results and remediation plans
- Compliance enhancement initiatives
- Regulatory strategy updates
3. Resource Needs
- Personnel hiring or training requirements
- Equipment purchases or upgrades
- Facility expansions or modifications
- IT system investments
- Budget allocations for quality activities
4. Changes to Quality Policy and Objectives
- Updates to quality policy statements
- Revision of quality objectives and targets
- New KPIs or measurement criteria
5. Action Items with Assignments
- Specific tasks with responsible individuals
- Timelines and deadlines for completion
- Follow-up mechanisms for tracking
Management Review meeting structure:
Frequency:
- Minimum annually per ISO 13485, but best practice is quarterly or semi-annually
- More frequent reviews during periods of significant change
- Ad-hoc reviews for urgent quality or regulatory issues
Attendees:
- Top management (CEO, President, General Manager)
- Quality/Regulatory Affairs leadership
- Operations/Manufacturing management
- Research & Development leadership
- Clinical Affairs (when applicable)
- Post-Market Surveillance lead
- Others as relevant to agenda topics
Typical agenda:
1. Review of previous meeting action items
2. Overview of QMS performance metrics
3. Internal and external audit results
4. Customer feedback and complaint analysis
5. CAPA status and effectiveness
6. Nonconformance trends
7. Post-market surveillance and vigilance data
8. Regulatory update and compliance status
9. Process performance and product quality
10. Resource needs and allocation
11. Opportunities for improvement
12. New action items and assignments
Documentation requirements:
Management review records must include:
- Meeting date, attendees, and duration
- All inputs reviewed with supporting data
- Discussions and deliberations
- Decisions made by management
- Action items with responsible parties and due dates
- Approval signatures from top management
- Distribution of minutes to relevant personnel
Best practices for effective Management Review:
Preparation:
- Distribute pre-read materials 1-2 weeks in advance
- Collect data and metrics from all relevant departments
- Prepare executive summaries highlighting key trends
- Use visual dashboards and charts for clarity
- Pre-identify critical issues requiring decisions
Execution:
- Allocate sufficient time (2-4 hours minimum)
- Focus on strategic and systemic issues, not operational details
- Encourage open discussion and diverse perspectives
- Make concrete decisions, not just observations
- Assign clear ownership and deadlines for actions
- Avoid information overload; prioritize critical topics
Follow-up:
- Distribute minutes within one week
- Track action items in centralized system
- Schedule progress check-ins between reviews
- Verify completion and effectiveness of actions
- Carry forward incomplete items to next review
Common pitfalls to avoid:
- Treating management review as a "check-the-box" compliance exercise
- Insufficient preparation or incomplete data
- Focus on positive news while avoiding difficult issues
- Lack of top management engagement or attendance
- No actionable decisions or resource commitments
- Failure to follow up on previous action items
- Inadequate documentation of discussions and decisions
Integration with other QMS processes:
Management Review connects to virtually all QMS elements:
- Internal Audit - Audit findings inform management review; review decisions may trigger audits
- CAPA - CAPA metrics reviewed; management decisions may initiate CAPAs
- Risk Management - Product and process risks assessed; resources allocated for risk mitigation
- Training - Training effectiveness reviewed; new training needs identified
- Design Control - New product performance reviewed; development resources allocated
- Post-Market Surveillance - Market data reviewed; field actions and vigilance assessed
- Supplier Management - Supplier performance reviewed; supplier development decisions made
Metrics commonly reviewed:
- Customer complaint rate and trends
- CAPA closure rate and overdue aging
- Internal audit findings by severity
- Nonconformance rate and scrap costs
- On-time delivery performance
- First-pass yield percentages
- Training completion rates
- Regulatory submission timelines
- Post-market surveillance metrics
- Customer satisfaction scores
Effective Management Review ensures that top leadership remains engaged with QMS performance, makes informed strategic decisions, allocates resources appropriately, and maintains a culture of quality and continuous improvement essential for medical device regulatory compliance and patient safety.
Related Terms
More Compliance & Standards
View allDie Qualitätssystemverordnung der FDA, die cGMP-Anforderungen (current Good Manufacturing Practice) für Medizinproduktehersteller in den USA festlegt.
Eine systematische, unabhängige Prüfung eines Qualitätsmanagementsystems, um festzustellen, ob Qualitätsaktivitäten und -ergebnisse den geplanten Vereinbarungen entsprechen und ob diese Vereinbarungen wirksam umgesetzt werden.
Ein systematischer Ansatz zur Untersuchung, Korrektur und Verhinderung von Qualitätsproblemen in der Medizinproduktherstellung und im Betrieb.
Eine obligatorische Konformitätskennzeichnung für im Europäischen Wirtschaftsraum verkaufte Medizinprodukte, die die Einhaltung der EU-Gesundheits-, Sicherheits- und Umweltschutzanforderungen anzeigt.
Need Help with Global Registration?
Pure Global provides regulatory consulting and AI-powered tools to help medical device companies navigate Global market access.

